Polyglutamine expansion diseases: Failing to deliver

Trends in Molecular Medicine

Volumn 11, Issue 2, 2005, Pages 64-70

  Morfini, Gerardo ^a   Pigino, Gustavo ^a   Brady, Scott T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNACTIN; POLYGLUTAMINE;

DEGENERATIVE DISEASE; ENERGY METABOLISM; ENZYME ACTIVITY; EXCITOTOXICITY; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUNTINGTON CHOREA; INTRACELLULAR TRANSPORT; NERVE CELL; NERVE CELL NECROSIS; NERVE ENDING; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; POLYGLUTAMINE EXPANSION DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SURVIVAL; TOXICITY;

EID: 13244297167     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.12.002     Document Type: Article

References (62)

1. H.Y. Zoghbi, and J. Botas Mouse and fly models of neurodegeneration Trends Genet. 18 2002 463 471
2. J.M. Ordway Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse Cell 91 1997 753 763
3. I. Dragatsis Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice Nat. Genet. 26 2000 300 306
4. I.A. Klement Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice Cell 95 1998 41 53
5. E. Cattaneo Loss of normal huntingtin function: new developments in Huntington's disease research Trends Neurosci. 24 2001 182 188
6. M. Katsuno Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Neuron 35 2002 843 854
7. J.F. Gusella, and M.E. MacDonald Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease Nat. Rev. Neurosci. 1 2000 109 115
8. H.Y. Zoghbi, and H.T. Orr Glutamine repeats and neurodegeneration Annu. Rev. Neurosci. 23 2000 217 247
9. P. Fernandez-Funez Identification of genes that modify ataxin-1-induced neurodegeneration Nature 408 2000 101 106
10. G. Gardian, and L. Vecsei Huntington's disease: pathomechanism and therapeutic perspectives J. Neural Transm. 111 2004 1485 1494
11. C.A. Ross Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders Neuron 35 2002 819 822
12. T. Grunewald, and M.F. Beal Bioenergetics in Huntington's disease Ann. N. Y. Acad. Sci. 893 1999 203 213
13. 2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease Arch. Biochem. Biophys. 410 2003 1 6
14. S.E. Browne Oxidative stress in Huntington's disease Brain Pathol. 9 1999 147 163
15. S.J. Tabrizi Biochemical abnormalities and excitotoxicity in Huntington's disease brain Ann. Neurol. 45 1999 25 32
16. B.J. Snider Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults Neuroscience 120 2003 617 625
17. L.W. Ho The molecular biology of Huntington's disease Psychol. Med. 31 2001 3 14
18. C. Soto Unfolding the role of protein misfolding in neurodegenerative diseases Nat. Rev. Neurosci. 4 2003 49 60
19. H.T. Orr Beyond the Qs in the polyglutamine diseases Genes Dev. 15 2001 925 932
20. S. Simeoni Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract Hum. Mol. Genet. 9 2000 133 144
21. F. Saudou Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions Cell 95 1998 55 66
22. M. Arrasate Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
23. G. Szebenyi Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport Neuron 40 2003 41 52
24. K. Ishikawa Abundant expression and cytoplasmic aggregations of α1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6 Hum. Mol. Genet. 8 1999 1185 1193
25. H. Li Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice J. Neurosci. 21 2001 8473 8481
26. K.J. Cowan Polyglutamine protein aggregation and toxicity are linked to the cellular stress response Hum. Mol. Genet. 12 2003 1377 1391
27. Y.F. Liu Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line J. Biol. Chem. 273 1998 28873 28877
28. S. Humbert The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt Dev. Cell 2 2002 831 837
29. H.K. Chen Interaction of akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1 Cell 113 2003 457 468
30. S. Brady Axonal transport methods and applications A. Boulton G. Baker Neuromethods, General Neurochemical Techniques Vol. 1 1985 Humana Press 419 476
31. G. Morfini Regulation of kinesin: implications for neuronal development Dev. Neurosci. 23 2001 364 376
32. G. Morfini Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility EMBO J. 21 2002 281 293
33. K-D. Lee, and P.J. Hollenbeck Phosphorylation of kinesin in vivo correlates with organelle association and neurite outgrowth J. Biol. Chem. 270 1995 5600 5605
34. G. Morfini A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons EMBO J. 23 2004 2235 2245
35. U. Beffert Reelin-mediated signaling locally regulates PKB/Akt and GSK-3β J. Biol. Chem. 277 2002 49958 49968
36. A.B. Bowman Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein Cell 103 2000 583 594
37. Z. Sahenk Studies on the pathogenesis of vincristine-induced neuropathy Muscle Nerve 10 1987 80 84
38. D.W. Sickles Direct effect of the neurotoxicant acrylamide on kinesin-based microtubule motility J. Neurosci. Res. 46 1996 7 17
39. C. Zhao Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ Cell 105 2001 587 597
40. E. Reid A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10) Am. J. Hum. Genet. 71 2002 1189 1194
41. M. Hafezparast Mutations in dynein link motor neuron degeneration to defects in retrograde transport Science 300 2003 808 812
42. G. Pigino Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport J. Neurosci. 23 2003 4499 4508
43. M. DiFiglia Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons Neuron 14 1995 1075 1081
44. F. Trettel Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells Hum. Mol. Genet. 9 2000 2799 2809
45. P.J. Skinner Altered trafficking of membrane proteins in purkinje cells of SCA1 transgenic mice Am. J. Pathol. 159 2001 905 913
46. F. Piccioni Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes FASEB J. 16 2002 1418 1420
47. W.C. Lee Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease Proc. Natl. Acad. Sci. U. S. A. 101 2004 3224 3229
48. S. Gunawardena Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila Neuron 40 2003 25 40
49. L.R. Gauthier Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 118 2004 127 138
50. A. Amaratunga Inhibition of kinesin synthesis and rapid anterograde axonal transport in vivo by antisense oligonucleotide J. Biol. Chem. 268 1993 17427 17430
51. F. Feiguin Kinesin-mediated organelle translocation revealed by specific cellular manipulations J. Cell Biol. 127 1994 1021 1039
52. M. Martin Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport Mol. Biol. Cell 10 1999 3717 3728
53. E. Trushina Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro Mol. Cell. Biol. 24 2004 8195 8209
54. S.H. Li, and X.J. Li Huntingtin-protein interactions and the pathogenesis of Huntington's disease Trends Genet. 20 2004 146 154
55. S.H. Li Interaction of huntingtin-associated protein with dynactin P150Glued J. Neurosci. 18 1998 1261 1269
56. R.J. Lasek, and S.T. Brady The structural hypothesis of axonal transport: two classes of moving elements D.G. Weiss Axoplasmic Transport 1982 Springer-Verlag 397 405
57. N. Hirokawa Kinesin and dynein superfamily proteins and the mechanism of organelle transport Science 279 1998 519 526
58. S.T. Brady, and A.O. Sperry Biochemical and functional diversity of microtubule motors in the nervous system Curr. Opin. Neurobiol. 5 1995 551 558
59. 2+-dependent dephosphorylation of kinesin heavy chain on β-granules in pancreatic β-cells. Implications for regulated β-granule transport and insulin exocytosis J. Biol. Chem. 277 2002 24232 24242
60. B. Ravikumar Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease Nat. Genet. 36 2004 585 595
61. J. Carmichael Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation J. Biol. Chem. 277 2002 33791 33798
62. N. Ratner A role for Cdk5 kinase in fast anterograde axonal transport: novel effects of olomoucine and the APC tumor suppressor protein J. Neurosci. 18 1998 7717 7726